Literature DB >> 5546922

Evidence suggesting 11 beta-hydroxylase inhibition during aminoglutethimide administration.

G Faglia, L Gattinoni, P Travaglini, V Neri, L Acerbi, B Ambrosi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5546922     DOI： 10.1016/0026-0495(71)90109-0

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  2 in total

1.  Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.

Authors:  A L Harris; M D Mitchell; I E Smith; T J Powles
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

2.  Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.

Authors:  A L Harris; M Dowsett; I E Smith; S L Jeffcoate
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.